Listed

Amylyx Pharmaceuticals, Inc.

AMLXNasdaqCIK 1658551HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025
Operating income−$45.7m, Q2 FY2026
Net income−$43.4m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m103Revenue, Q3 FY2023, three months to 2023-09-30$102.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure108Revenue, Q4 FY2023, three months to 2023-12-31$108.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure88.6Revenue, Q1 FY2024, three months to 2024-03-31$88.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure(1.0)Revenue, Q2 FY2024, three months to 2024-06-30−$1.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure0.4Revenue, Q3 FY2024, three months to 2024-09-30$416.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure(0.7)Revenue, Q4 FY2024, three months to 2024-12-31−$665.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Cost of revenue$m5.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$5.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure9.4Cost of revenue, Q4 FY2023, three months to 2023-12-31$9.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure5.9Cost of revenue, Q1 FY2024, three months to 2024-03-31$5.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure0.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$8.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure0.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure0.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure0.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Research and development$m30.0Research and development, Q3 FY2023, three months to 2023-09-30$30.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure44.9Research and development, Q4 FY2023, three months to 2023-12-31$44.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure36.6Research and development, Q1 FY2024, three months to 2024-03-31$36.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure23.3Research and development, Q2 FY2024, three months to 2024-06-30$23.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure21.2Research and development, Q3 FY2024, three months to 2024-09-30$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure22.9Research and development, Q4 FY2024, three months to 2024-12-31$22.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure22.1Research and development, Q1 FY2025, three months to 2025-03-31$22.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure27.2Research and development, Q2 FY2025, three months to 2025-06-30$27.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure19.9Research and development, Q3 FY2025, three months to 2025-09-30$19.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure21.2Research and development, Q4 FY2025, three months to 2025-12-31$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure27.6Research and development, Q1 FY2026, three months to 2026-03-31$27.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure23.8Research and development, Q2 FY2026, three months to 2026-06-30$23.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Selling, general and administrative$m48.7Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$48.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure52.2Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$52.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure57.8Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$57.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure21.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$21.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure17.8Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$17.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure17.1Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$17.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure15.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$15.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure15.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$15.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure16.2Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$16.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure15.4Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$15.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure16.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$16.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure21.9Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$21.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Operating income$m18.7Operating income, Q3 FY2023, three months to 2023-09-30$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure1.9Operating income, Q4 FY2023, three months to 2023-12-31$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure(122)Operating income, Q1 FY2024, three months to 2024-03-31−$122.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure(76.3)Operating income, Q2 FY2024, three months to 2024-06-30−$76.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure(75.7)Operating income, Q3 FY2024, three months to 2024-09-30−$75.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure(40.7)Operating income, Q4 FY2024, three months to 2024-12-31−$40.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure(37.8)Operating income, Q1 FY2025, three months to 2025-03-31−$37.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure(42.9)Operating income, Q2 FY2025, three months to 2025-06-30−$42.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure(36.0)Operating income, Q3 FY2025, three months to 2025-09-30−$36.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure(36.6)Operating income, Q4 FY2025, three months to 2025-12-31−$36.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure(43.8)Operating income, Q1 FY2026, three months to 2026-03-31−$43.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure(45.7)Operating income, Q2 FY2026, three months to 2026-06-30−$45.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Income tax$m1.5Income tax, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure1.7Income tax, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2024, three months to 2024-03-31$242.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure(0.6)Income tax, Q4 FY2024, three months to 2024-12-31−$635.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$46.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$m20.9Net income, Q3 FY2023, three months to 2023-09-30$20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure4.7Net income, Q4 FY2023, three months to 2023-12-31$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure(119)Net income, Q1 FY2024, three months to 2024-03-31−$118.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure(72.7)Net income, Q2 FY2024, three months to 2024-06-30−$72.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure(72.7)Net income, Q3 FY2024, three months to 2024-09-30−$72.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure(37.5)Net income, Q4 FY2024, three months to 2024-12-31−$37.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure(35.9)Net income, Q1 FY2025, three months to 2025-03-31−$35.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure(41.4)Net income, Q2 FY2025, three months to 2025-06-30−$41.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure(34.4)Net income, Q3 FY2025, three months to 2025-09-30−$34.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure(33.0)Net income, Q4 FY2025, three months to 2025-12-31−$33.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure(41.3)Net income, Q1 FY2026, three months to 2026-03-31−$41.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure(43.4)Net income, Q2 FY2026, three months to 2026-06-30−$43.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Diluted EPS$ per share0.30Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figurenot reported(1.75)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure(1.07)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure(1.07)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figurenot reported(0.42)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure(0.46)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure(0.37)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figurenot reported(0.37)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure(0.39)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Basic EPS$ per share0.31Basic EPS, Q3 FY2023, three months to 2023-09-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figurenot reported(1.75)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure(1.07)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure(1.07)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figurenot reported(0.42)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure(0.46)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure(0.37)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figurenot reported(0.37)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure(0.39)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure

Balance sheet

Cash and equivalents$49.3m, Q2 FY2026
Shareholders' equity$239.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m135Cash and equivalents, Q3 FY2023, at 2023-09-30$135.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure170Cash and equivalents, FY2023, at 2023-12-31$170.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-04, accession 0000950170-25-031309.Report this figure171Cash and equivalents, Q1 FY2024, at 2024-03-31$170.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure75.0Cash and equivalents, Q2 FY2024, at 2024-06-30$75.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure71.8Cash and equivalents, Q3 FY2024, at 2024-09-30$71.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure77.4Cash and equivalents, FY2024, at 2024-12-31$77.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-03, accession 0001193125-26-086645.Report this figure59.8Cash and equivalents, Q1 FY2025, at 2025-03-31$59.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure58.1Cash and equivalents, Q2 FY2025, at 2025-06-30$58.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure225Cash and equivalents, Q3 FY2025, at 2025-09-30$225.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure227Cash and equivalents, FY2025, at 2025-12-31$226.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure229Cash and equivalents, Q1 FY2026, at 2026-03-31$229.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure49.3Cash and equivalents, Q2 FY2026, at 2026-06-30$49.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Current assets$m434Current assets, Q3 FY2023, at 2023-09-30$434.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061516.Report this figure465Current assets, FY2023, at 2023-12-31$464.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-04, accession 0000950170-25-031309.Report this figure411Current assets, Q1 FY2024, at 2024-03-31$410.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056269.Report this figure327Current assets, Q2 FY2024, at 2024-06-30$326.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093311.Report this figure245Current assets, Q3 FY2024, at 2024-09-30$245.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure189Current assets, FY2024, at 2024-12-31$189.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-03, accession 0001193125-26-086645.Report this figure216Current assets, Q1 FY2025, at 2025-03-31$216.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure187Current assets, Q2 FY2025, at 2025-06-30$186.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure353Current assets, Q3 FY2025, at 2025-09-30$353.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure324Current assets, FY2025, at 2025-12-31$323.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure285Current assets, Q1 FY2026, at 2026-03-31$285.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure256Current assets, Q2 FY2026, at 2026-06-30$256.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Total assets$m467Total assets, Q3 FY2023, at 2023-09-30$466.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-061516.Report this figure517Total assets, FY2023, at 2023-12-31$517.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-04, accession 0000950170-25-031309.Report this figure417Total assets, Q1 FY2024, at 2024-03-31$417.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056269.Report this figure332Total assets, Q2 FY2024, at 2024-06-30$332.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093311.Report this figure251Total assets, Q3 FY2024, at 2024-09-30$250.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure194Total assets, FY2024, at 2024-12-31$193.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-03, accession 0001193125-26-086645.Report this figure220Total assets, Q1 FY2025, at 2025-03-31$219.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure195Total assets, Q2 FY2025, at 2025-06-30$194.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure363Total assets, Q3 FY2025, at 2025-09-30$362.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure333Total assets, FY2025, at 2025-12-31$332.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure294Total assets, Q1 FY2026, at 2026-03-31$293.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure265Total assets, Q2 FY2026, at 2026-06-30$264.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Current liabilities$m45.6Current liabilities, Q3 FY2023, at 2023-09-30$45.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061516.Report this figure82.0Current liabilities, FY2023, at 2023-12-31$82.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-04, accession 0000950170-25-031309.Report this figure91.6Current liabilities, Q1 FY2024, at 2024-03-31$91.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056269.Report this figure70.1Current liabilities, Q2 FY2024, at 2024-06-30$70.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093311.Report this figure53.9Current liabilities, Q3 FY2024, at 2024-09-30$53.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure28.4Current liabilities, FY2024, at 2024-12-31$28.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-03, accession 0001193125-26-086645.Report this figure17.9Current liabilities, Q1 FY2025, at 2025-03-31$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure21.4Current liabilities, Q2 FY2025, at 2025-06-30$21.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure25.8Current liabilities, Q3 FY2025, at 2025-09-30$25.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure22.7Current liabilities, FY2025, at 2025-12-31$22.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure16.0Current liabilities, Q1 FY2026, at 2026-03-31$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure21.2Current liabilities, Q2 FY2026, at 2026-06-30$21.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Total liabilities$m48.2Total liabilities, Q3 FY2023, at 2023-09-30$48.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-061516.Report this figure84.0Total liabilities, FY2023, at 2023-12-31$84.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-04, accession 0000950170-25-031309.Report this figure93.0Total liabilities, Q1 FY2024, at 2024-03-31$93.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056269.Report this figure70.9Total liabilities, Q2 FY2024, at 2024-06-30$70.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093311.Report this figure54.5Total liabilities, Q3 FY2024, at 2024-09-30$54.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure28.9Total liabilities, FY2024, at 2024-12-31$28.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-03, accession 0001193125-26-086645.Report this figure18.3Total liabilities, Q1 FY2025, at 2025-03-31$18.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure26.7Total liabilities, Q2 FY2025, at 2025-06-30$26.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure30.7Total liabilities, Q3 FY2025, at 2025-09-30$30.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure27.4Total liabilities, FY2025, at 2025-12-31$27.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure20.4Total liabilities, Q1 FY2026, at 2026-03-31$20.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure25.4Total liabilities, Q2 FY2026, at 2026-06-30$25.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure
Shareholders' equity$m418Shareholders' equity, Q3 FY2023, at 2023-09-30$418.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure433Shareholders' equity, FY2023, at 2023-12-31$433.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-03, accession 0001193125-26-086645.Report this figure324Shareholders' equity, Q1 FY2024, at 2024-03-31$324.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure261Shareholders' equity, Q2 FY2024, at 2024-06-30$261.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure196Shareholders' equity, Q3 FY2024, at 2024-09-30$196.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure165Shareholders' equity, FY2024, at 2024-12-31$164.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure201Shareholders' equity, Q1 FY2025, at 2025-03-31$201.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure168Shareholders' equity, Q2 FY2025, at 2025-06-30$167.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure332Shareholders' equity, Q3 FY2025, at 2025-09-30$332.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure305Shareholders' equity, FY2025, at 2025-12-31$305.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure273Shareholders' equity, Q1 FY2026, at 2026-03-31$273.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure239Shareholders' equity, Q2 FY2026, at 2026-06-30$239.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure

Cash flow

Operating cash flow−$31.4m, Q2 FY2026
Capital expenditure$86.0k, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(5.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122833. Derived: 9-month figure less the 6-month figure.Report this figure13.6Operating cash flow, Q4 FY2023, three months to 2023-12-31$13.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$489.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure(66.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$66.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001193125-25-174948. Derived: 6-month figure less the 3-month figure.Report this figure(41.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$41.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268059. Derived: 9-month figure less the 6-month figure.Report this figure(59.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$59.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure(39.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$39.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure(25.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$25.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336682. Derived: 6-month figure less the 3-month figure.Report this figure(30.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$30.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268059. Derived: 9-month figure less the 6-month figure.Report this figure(27.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$27.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure(36.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$36.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure(31.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$31.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336682. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$357.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122833. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$356.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-04, accession 0000950170-25-031309. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$67.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$89.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001193125-25-174948. Derived: 6-month figure less the 3-month figure.Report this figure(0.0)Capital expenditure, Q3 FY2024, three months to 2024-09-30−$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268059. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336682. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268059. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001193125-26-086645. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)111.20m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares58.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3058,533,226 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-061516.Report this figure70.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3170,863,665 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056269.Report this figure70.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3070,132,040 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093311.Report this figure69.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3069,748,547 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122833.Report this figure67.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3167,854,356 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066363.Report this figure68.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3068,024,929 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001193125-25-174948.Report this figure68.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3068,091,446 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure85.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3185,697,108 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure89.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3089,138,568 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure93.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3093,332,930 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268059.Report this figure111Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31110,563,360 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210292.Report this figure111Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30111,196,883 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure

Shares outstanding: 111.42mShares outstanding, period not labelled, at 2026-07-27111,423,048 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336682.Report this figure at Jul 27, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.